Back

One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry.

28 August 2023 (13:15 - 13:45)
Organised by: Logo
Congress Presentation Part of: Medical therapy for acute heart failure and changing outcomes Cardiogenic Shock ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Philippe Maury

Rangueil Hospital of Toulouse, Toulouse (France)

4 More presentations in this session

Presentation thumbnail
Impact of in-hospital initiation of sodium-glucose cotransporter-2 inhibitors in patients with heart failure and reduced ejection fraction
Ms M. Diez (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Evidence-based heart failure therapies at discharge of patients with acute coronary syndromes and reduced ejection fraction: Data from the ACSIS survey
Doctor F. Bahouth (Nazareth, IL)
Abstract Slides Video
Presentation thumbnail
Association between sex and efficacy of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency: an AFFIRM-AHF subgroup analysis
Professor G. Rosano (London, GB)
Abstract Slides Video
Presentation thumbnail
SGLT2 inhibitors and vericiguat in real-world patients admitted for worsening heart failure
Doctor R. Tarantini (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Medical therapy for acute heart failure and changing outcomes

The Event

Event poster

ESC Congress 2023

28 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Epidemiology, outcomes and classifications
thumbnail
Congress Presentation
Acute MI shock vs heart failure shock: are they the same?
thumbnail
Congress Presentation
Characteristics and prognostic implications of pre-shock and normotensive cardiogenic shock in the Critical Care Cardiology Trials Network Registry

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources